HEADER TRANSFERASE 24-OCT-17 6BDR TITLE SCHISTOSOMA MANSONI (BLOOD FLUKE) SULFOTRANSFERASE/CIDD-0000206 TITLE 2 (COMPOUND 9F) COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SULFOTRANSFERASE OXAMNIQUINE RESISTANCE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHISTOSOMA MANSONI; SOURCE 3 ORGANISM_COMMON: BLOOD FLUKE; SOURCE 4 ORGANISM_TAXID: 6183; SOURCE 5 GENE: SULT-OR, SMP_089320; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PAG8H KEYWDS SULFOTRANSFERASE, PARASITE, DRUG RESISTANCE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.B.TAYLOR REVDAT 4 01-MAY-24 6BDR 1 COMPND HETNAM FORMUL REVDAT 3 04-OCT-23 6BDR 1 REMARK REVDAT 2 07-NOV-18 6BDR 1 SOURCE JRNL REVDAT 1 03-OCT-18 6BDR 0 JRNL AUTH A.RUGEL,R.S.TARPLEY,A.LOPEZ,T.MENARD,M.A.GUZMAN,A.B.TAYLOR, JRNL AUTH 2 X.CAO,D.KOVALSKYY,F.D.CHEVALIER,T.J.C.ANDERSON,P.J.HART, JRNL AUTH 3 P.T.LOVERDE,S.F.MCHARDY JRNL TITL DESIGN, SYNTHESIS, AND CHARACTERIZATION OF NOVEL SMALL JRNL TITL 2 MOLECULES AS BROAD RANGE ANTISCHISTOSOMAL AGENTS. JRNL REF ACS MED CHEM LETT V. 9 967 2018 JRNL REFN ISSN 1948-5875 JRNL PMID 30344901 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00257 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2919 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 36092 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.540 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.9293 - 3.9994 0.94 2501 147 0.1408 0.1575 REMARK 3 2 3.9994 - 3.1749 0.99 2477 145 0.1326 0.1710 REMARK 3 3 3.1749 - 2.7737 1.00 2477 146 0.1552 0.1955 REMARK 3 4 2.7737 - 2.5202 1.00 2459 144 0.1550 0.2152 REMARK 3 5 2.5202 - 2.3396 1.00 2434 142 0.1448 0.2273 REMARK 3 6 2.3396 - 2.2017 1.00 2443 143 0.1339 0.2060 REMARK 3 7 2.2017 - 2.0914 1.00 2431 144 0.1324 0.1890 REMARK 3 8 2.0914 - 2.0004 1.00 2424 141 0.1409 0.1987 REMARK 3 9 2.0004 - 1.9234 1.00 2420 143 0.1402 0.2129 REMARK 3 10 1.9234 - 1.8570 1.00 2408 140 0.1474 0.2142 REMARK 3 11 1.8570 - 1.7989 1.00 2381 140 0.1608 0.2371 REMARK 3 12 1.7989 - 1.7475 1.00 2442 144 0.1804 0.2518 REMARK 3 13 1.7475 - 1.7015 1.00 2385 139 0.2123 0.3044 REMARK 3 14 1.7015 - 1.6600 1.00 2410 142 0.2439 0.3482 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 2233 REMARK 3 ANGLE : 1.315 3039 REMARK 3 CHIRALITY : 0.059 340 REMARK 3 PLANARITY : 0.007 375 REMARK 3 DIHEDRAL : 15.231 836 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BDR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1000229714. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36148 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 37.919 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09000 REMARK 200 FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 1.06500 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4MUA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M SODIUM CITRATE, 0.1 M SODIUM REMARK 280 CACODYLATE PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 70.63550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.68200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.63550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 19.68200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 282.54200 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 627 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 45 54.06 -146.33 REMARK 500 ASP A 91 171.08 74.80 REMARK 500 VAL A 127 -56.60 -125.78 REMARK 500 ASN A 150 -158.36 -122.59 REMARK 500 ASN A 228 33.07 74.68 REMARK 500 ASP A 255 -27.38 72.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 DF7 A 303 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A3P A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DF7 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DF7 A 303 DBREF 6BDR A 1 257 UNP G4VLE5 G4VLE5_SCHMA 1 257 SEQADV 6BDR GLY A -1 UNP G4VLE5 EXPRESSION TAG SEQADV 6BDR ALA A 0 UNP G4VLE5 EXPRESSION TAG SEQRES 1 A 259 GLY ALA MET ILE GLU SER SER THR THR ILE GLN VAL ILE SEQRES 2 A 259 SER ALA GLY LEU PRO ARG THR GLY THR LYS SER LEU LYS SEQRES 3 A 259 ASN ALA LEU GLU ILE ILE TYR HIS LYS PRO CYS TYR HIS SEQRES 4 A 259 MET PHE GLU ILE ILE PHE ASN LYS GLN SER ASP ILE ILE SEQRES 5 A 259 LYS TRP GLN ASN LEU ILE HIS ASP SER HIS MET ILE THR SEQRES 6 A 259 THR PRO PRO PRO LEU THR THR LYS THR ILE ALA ILE TYR SEQRES 7 A 259 ASP LYS LEU LYS GLU LEU LEU ASP GLY TYR ILE ALA THR SEQRES 8 A 259 THR ASP LEU PRO THR CYS GLY PHE TYR LYS ASP LEU MET SEQRES 9 A 259 ASN ILE TYR PRO ASN ALA LYS VAL LEU LEU THR ILE ARG SEQRES 10 A 259 ASP LYS TYR ASP TRP LEU HIS SER LEU ARG LYS VAL VAL SEQRES 11 A 259 LEU PRO LYS SER ASN ASP PRO TRP LYS LEU LYS ILE GLU SEQRES 12 A 259 GLU GLY ASP LYS VAL LEU GLY LEU ASN SER ASP PHE TYR SEQRES 13 A 259 LYS LEU THR GLU ASP SER LEU LYS PHE ALA PHE GLN LYS SEQRES 14 A 259 ASP ASP LEU ASN PHE ASP ASP ASP GLN VAL LEU LEU GLU SEQRES 15 A 259 CYS TYR ASP GLU TYR ASN ARG LEU VAL GLN GLU THR VAL SEQRES 16 A 259 PRO SER ASP ARG LEU LEU VAL LEU ARG LEU GLY ASP GLY SEQRES 17 A 259 TRP GLU PRO LEU CYS LYS PHE LEU ASN VAL GLU ILE PRO SEQRES 18 A 259 ASN GLY ILE ASP TYR PRO CAS VAL ASN SER HIS HIS GLN SEQRES 19 A 259 MET THR GLN LEU THR GLU GLN LEU ILE LYS TYR LYS SER SEQRES 20 A 259 LEU ASP ALA ILE ILE HIS MET PHE PRO ASP LEU ILE MODRES 6BDR CAS A 226 CYS MODIFIED RESIDUE HET CAS A 226 9 HET A3P A 301 27 HET DF7 A 302 27 HET DF7 A 303 13 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM A3P ADENOSINE-3'-5'-DIPHOSPHATE HETNAM DF7 [4-({(3R)-1-[(1H-INDOL-3-YL)METHYL]PYRROLIDIN-3- HETNAM 2 DF7 YL}AMINO)-2-NITROPHENYL]METHANOL FORMUL 1 CAS C5 H12 AS N O2 S FORMUL 2 A3P C10 H15 N5 O10 P2 FORMUL 3 DF7 2(C20 H22 N4 O3) FORMUL 5 HOH *236(H2 O) HELIX 1 AA1 GLY A 19 HIS A 32 1 14 HELIX 2 AA2 HIS A 37 LYS A 45 1 9 HELIX 3 AA3 ASP A 48 SER A 59 1 12 HELIX 4 AA4 HIS A 60 ILE A 62 5 3 HELIX 5 AA5 THR A 69 LEU A 83 1 15 HELIX 6 AA6 THR A 94 GLY A 96 5 3 HELIX 7 AA7 PHE A 97 TYR A 105 1 9 HELIX 8 AA8 ASP A 116 VAL A 128 1 13 HELIX 9 AA9 ASP A 134 LEU A 147 1 14 HELIX 10 AB1 ASN A 150 GLN A 166 1 17 HELIX 11 AB2 ASP A 174 VAL A 193 1 20 HELIX 12 AB3 PRO A 194 ASP A 196 5 3 HELIX 13 AB4 GLY A 206 ASN A 215 1 10 HELIX 14 AB5 SER A 229 LYS A 244 1 16 HELIX 15 AB6 ILE A 249 PHE A 253 5 5 SHEET 1 AA1 5 CYS A 35 TYR A 36 0 SHEET 2 AA1 5 ALA A 88 THR A 89 1 O ALA A 88 N TYR A 36 SHEET 3 AA1 5 VAL A 10 SER A 12 1 N SER A 12 O THR A 89 SHEET 4 AA1 5 LYS A 109 ILE A 114 1 O LYS A 109 N ILE A 11 SHEET 5 AA1 5 LEU A 198 ARG A 202 1 O LEU A 201 N LEU A 112 LINK C PRO A 225 N CAS A 226 1555 1555 1.32 LINK C CAS A 226 N VAL A 227 1555 1555 1.31 CISPEP 1 PRO A 65 PRO A 66 0 -0.37 CISPEP 2 PRO A 66 PRO A 67 0 -6.16 CISPEP 3 LEU A 92 PRO A 93 0 -0.07 SITE 1 AC1 21 ARG A 17 THR A 18 GLY A 19 THR A 20 SITE 2 AC1 21 LYS A 21 SER A 22 ARG A 115 SER A 123 SITE 3 AC1 21 LEU A 203 PRO A 225 CAS A 226 VAL A 227 SITE 4 AC1 21 ASN A 228 SER A 229 HIS A 230 HOH A 426 SITE 5 AC1 21 HOH A 440 HOH A 448 HOH A 454 HOH A 486 SITE 6 AC1 21 HOH A 558 SITE 1 AC2 14 PRO A 16 HIS A 37 MET A 38 ASP A 91 SITE 2 AC2 14 LEU A 92 VAL A 127 VAL A 128 LYS A 137 SITE 3 AC2 14 ILE A 140 GLU A 141 ASP A 144 THR A 157 SITE 4 AC2 14 GLU A 158 HOH A 454 SITE 1 AC3 4 LEU A 68 ILE A 73 TYR A 76 ASN A 103 CRYST1 141.271 39.364 53.627 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007079 0.000000 0.000000 0.00000 SCALE2 0.000000 0.025404 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018647 0.00000